SEC 13F Intelligence

Altium Capital Management LLC / HAE

Altium Capital Management LLC’s Haemonetics Corp Mass Position

Does Altium Capital Management LLC own Haemonetics Corp Mass (HAE)? Not currently — the last reported position was 74.0K shares worth $5M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2021
Shares
74.0K
% of Portfolio
+1.37%
Quarters Held
4
position exited

Position History HAE

Reported value by quarter
Q4 ’20: $3MQ4 ’20Q1 ’21: $2MQ1 ’21Q2 ’21: $4MQ2 ’21Q3 ’21: $5MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202174.0K$5M+1.37%
Q2 202153.0K$4M+0.82%
Q1 202117.0K$2M+0.53%
Q4 202026.1K$3M+1.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of HAE.